Clinical trial
Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic…
NCT00004187 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00004187 |
|---|---|
| Title | Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer |
| Official title | A Phase I-II Study of Capecitabine and Oxaliplatin in Chemotherapy-Naive and Thymidylate Synthase Inhibitor Pretreated Advanced or Metastatic Colorectal Cancer |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, oxaliplatin |
| Start date | Jun 1, 1999 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Aug 5, 2004 |
| Last update posted | Jun 26, 2019 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: